Top 5 Cheap Stocks To Own For 2019

Redfin (RDFN), or “Real Estate Redefined” in an abbreviated form, is one of the exciting new unicorn IPOs of 2017. Taking the massive real estate market and flipping it on its head is the goal of RDFN. They are attempting to be a disruptor in the space, and the Q2 2017 results show some great promise going forward. Knowledgeable real estate names like Zillow (ZG) CEO Spencer Rascoff realize RDFN is a large threat to the industry as a whole. By streamlining the home buying process and lowering broker fees, RDFN looks to make buying a home cheaper and easier. Technology is the foundation of the company, and young millennial home buyers aged 25-40 are the target audience. As this generation ages over the next 5-10 years, Redfin can expand with the tech savvy masses. Redfin is poised for some large growth years ahead of it, but the stock price is certainly more of a question mark. While I am impressed by the growth rate and results, the stock sits at quite the lofty valuation. Let’s take a look at the Q2 numbers and see if it is worth its $2.2B valuation at the moment.

Top 5 Cheap Stocks To Own For 2019: International Business Machines Corporation(IBM)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    An IBM (NYSE: IBM) hardware system was used to help complete the project.

    ALSO READ: 12 American Companies That Control Tech

  • [By Chris Lange]

    So how does International Business Machines Corp. (NYSE: IBM) compare to the markets over the past nine years?

    On an adjusted close basis, IBM closed March 6, 2009, at $68.36 a share, or $85.81 on an unadjusted basis. IBM most recently closed at $155.83 on an adjusted basis.

  • [By ]

    Earnings will once again dominate the early portion of the trading day, with first quarter reports from Dow components in Action Alerts PLUS holding UnitedHealth (UNH) , Johnson & Johnson (JNJ)  , Goldman Sachs (GS) and IBM Corp. (IBM) . 

  • [By Anders Bylund, Timothy Green, and Dan Caplinger]

    Anders Bylund (IBM): I know, IBM isn’t supposed to get growth investors all excited. The technology veteran has seen nothing but shrinking revenues over the last five years alongside stable profits, at best. Over the same period, stock prices fell 29% lower and IBM investors missed out on a 70% growth spurt in the broader market.

  • [By Anders Bylund]

    Computing giant IBM (NYSE:IBM) reported first-quarter results on Tuesday. Currency exchange effects and a large bundle of tax credits led to mixed results, as Big Blue continued to restructure around its so-called strategic imperatives.

Top 5 Cheap Stocks To Own For 2019: S&P Smallcap 600(PH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Parker Hannifin (PH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Barings LLC decreased its holdings in Parker Hannifin (NYSE:PH) by 36.4% in the first quarter, HoldingsChannel reports. The firm owned 26,064 shares of the industrial products company’s stock after selling 14,937 shares during the period. Barings LLC’s holdings in Parker Hannifin were worth $4,458,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Ardevora Asset Management LLP reduced its stake in shares of Parker Hannifin (NYSE:PH) by 0.5% in the first quarter, HoldingsChannel.com reports. The fund owned 154,400 shares of the industrial products company’s stock after selling 800 shares during the quarter. Ardevora Asset Management LLP’s holdings in Parker Hannifin were worth $26,407,000 as of its most recent filing with the Securities & Exchange Commission.

Top 5 Cheap Stocks To Own For 2019: Sirius XM Radio Inc.(SIRI)

Advisors’ Opinion:

  • [By Rick Munarriz]

    Shares of Sirius XM Holdings (NASDAQ:SIRI)hit another 12-year high on Monday. The country’s lone satellite radio provider would go on to improve its fundamentals, announcing that it’s laying to rest a pending legal matter by settling with SoundExchange.

  • [By ]

    Berkshire’s biggest winners in the stock market so far this year are MasterCard Inc. (MA) , up 23%; Sirius XM Holdings Inc. (SIRI) , up 18%; Phillips 66 (PSX) , up 14%; Visa Inc. (V) , up 11%; and Moody’s Corp. (MCO) , also up 11%, according to FactSet.

  • [By Daniel B. Kline]

    When Sirius and XM merged in 2008 to become Sirius XM Holdings Inc.(NASDAQ:SIRI), the combined company still filled a need. It offered depth and niche choices in music that conventional radio did not. In addition, the service had talk offerings led by Howard Stern that were unlike anything found on terrestrial radio, and an impressive array of sports broadcasting rights.

  • [By Jon C. Ogg]

    Sirius XM Holdings Inc. (NASDAQ: SIRI) is a company that thrives on of new car sales. If you have had satellite radio and are not solely reliant on what you get for music in streaming or your library, then chances are pretty good that you won’t want to go back to just having old-fashioned FM/AM radio.

  • [By ]

    However, several Buffett stocks chalked up nice gains during the first quarter. The three top performers in Berkshire’s portfolio were Sirius XM Holdings (NASDAQ:SIRI), Mastercard (NYSE:MA), and Moody’s (NYSE:MCO). Here’s what drove these stocks higher — and what their prospects are for the rest of 2018.

  • [By Joseph Griffin]

    Toronto Dominion Bank raised its position in shares of Sirius XM Holdings Inc (NASDAQ:SIRI) by 36.7% in the first quarter, HoldingsChannel.com reports. The fund owned 130,110 shares of the company’s stock after buying an additional 34,955 shares during the quarter. Toronto Dominion Bank’s holdings in Sirius XM were worth $812,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 5 Cheap Stocks To Own For 2019: Wendy’s/Arby’s Group Inc.(WEN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Wendy’s (NASDAQ:WEN) major shareholder Edward P. Garden sold 764,000 shares of the business’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $16.53, for a total value of $12,628,920.00. Following the completion of the sale, the insider now directly owns 240,365 shares of the company’s stock, valued at approximately $3,973,233.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

  • [By Jeremy Bowman]

    The chart below shows how McDonald’s compares with some of its closest peers based on its valuation and expected growth rate.

    Company P/E Ratio 2-Year Expected EPS Growth Rate
    McDonald’s (NYSE:MCD) 26.2 23.6%
    Starbucks (NASDAQ:SBUX) 26.2 27.3%
    Wendy’s (NASDAQ:WEN) 21.8 58.1%
    Restaurant Brands International(NYSE:QSR) 21.4 41.9%
    Yum! Brands(NYSE:YUM) 23.2 29.7%

    Data source: Yahoo! Finance. EPS = earnings per share.

  • [By Shane Hupp]

    Wendy’s (NASDAQ:WEN)‘s stock had its “buy” rating reiterated by equities researchers at Argus in a research note issued to investors on Thursday. They currently have a $16.34 price target on the restaurant operator’s stock, down from their prior price target of $19.00.

  • [By Joseph Griffin]

    Hsbc Holdings PLC lowered its position in shares of Wendys Co (NASDAQ:WEN) by 91.6% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 27,590 shares of the restaurant operator’s stock after selling 299,154 shares during the quarter. Hsbc Holdings PLC’s holdings in Wendys were worth $484,000 as of its most recent filing with the Securities & Exchange Commission.

Top 5 Cheap Stocks To Own For 2019: UnitedHealth Group Incorporated(UNH)

Advisors’ Opinion:

  • [By Paul Ausick]

    Before the opening bell Tuesday, Dow Jones Industrial Average component UnitedHealth Group Inc. (NYSE: UNH) is expected to report another solid quarter. After all, the company has beat analysts’ earnings estimate for eight straight quarters and revenues in six of those eight.

  • [By Dan Caplinger]

    Health insurance giant UnitedHealth Group (NYSE:UNH) has done an admirable job of navigating the ever-changing landscape of healthcare reform over the past several years. The company was slow to embrace the health insurance exchanges set out in the Affordable Care Act, and that helped leave UnitedHealth less vulnerable when the Trump administration sought to repeal and replace Obamacare. Even as many focused on the positives of tax reform, UnitedHealth had to find ways to navigate the return of the excise tax on health insurance premiums in 2018 without seeing a material negative impact to its bottom line.

  • [By ]

    On Tuesday, he’ll be tuning into UnitedHealth Group (UNH) , Goldman Sachs (GS) , Johnson & Johnson (JNJ) and IBM (IBM) . Cramer had great things to say about all four companies.

JPMorgan Chase Cuts AmBev (ABEV) Price Target to $6.50

AmBev (NYSE:ABEV) had its target price dropped by JPMorgan Chase from $7.50 to $6.50 in a research report issued on Tuesday. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase’s target price points to a potential upside of 18.83% from the company’s current price.

ABEV has been the topic of a number of other research reports. ValuEngine cut AmBev from a “hold” rating to a “sell” rating in a research note on Monday, May 14th. Zacks Investment Research upgraded AmBev from a “hold” rating to a “buy” rating and set a $7.00 price target on the stock in a research note on Wednesday, May 9th. UBS upgraded AmBev from a “market perform” rating to an “outperform” rating in a research note on Friday, February 9th. Finally, TheStreet upgraded AmBev from a “c+” rating to a “b” rating in a research note on Monday, March 5th. Two analysts have rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $7.38.

Get AmBev alerts:

Shares of AmBev traded up $0.01, hitting $5.47, during trading hours on Tuesday, according to Marketbeat. The company had a trading volume of 162,623 shares, compared to its average volume of 23,066,786. The company has a market cap of $86.51 billion, a PE ratio of 23.78, a PEG ratio of 0.93 and a beta of 0.61. The company has a current ratio of 0.94, a quick ratio of 0.74 and a debt-to-equity ratio of 0.07. AmBev has a 1-year low of $5.30 and a 1-year high of $7.43.

AmBev (NYSE:ABEV) last posted its quarterly earnings results on Wednesday, May 9th. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.02). AmBev had a net margin of 16.15% and a return on equity of 24.66%. The business had revenue of $3.59 billion during the quarter, compared to the consensus estimate of $3.65 billion. sell-side analysts predict that AmBev will post 0.28 EPS for the current fiscal year.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Oppenheimer Asset Management Inc. bought a new position in AmBev during the 1st quarter worth $106,000. Clearbridge Investments LLC bought a new position in AmBev during the 4th quarter worth $105,000. Arnhold LLC bought a new position in AmBev during the 1st quarter worth $130,000. Premia Global Advisors LLC bought a new position in AmBev during the 4th quarter worth $134,000. Finally, Brown Advisory Inc. increased its position in AmBev by 82.2% during the 4th quarter. Brown Advisory Inc. now owns 22,136 shares of the company’s stock worth $144,000 after buying an additional 9,989 shares during the period. Institutional investors and hedge funds own 6.92% of the company’s stock.

About AmBev

Ambev SA, through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks (CSD), other non-alcoholic beverages, malt, and food in the Americas. It operates through Latin America North, Latin America South, and Canada segments. The company offers beer primarily under the Skol, Brahma, Antarctic, Brahva, Brahva Gold, Extra, Budweiser, Bud Light, Stella Artois, Corona, Modelo Especial, Beck, Leffe, Hoegaarden, Presidente, Brahma Light, President Light, Bohemia, The One, Quilmes Cl谩sica, Pace帽a, Taqui帽a, Huari, Becker, B谩ltica, Ouro Fino, Pilsen, Patricia, Labatt Blue, Alexander Keith's, Kokanee, Banks, and Deputy brands.

Analyst Recommendations for AmBev (NYSE:ABEV)

If You Like Dividends, You Should Love These 3 Stocks

If you don’t like dividends, you should. Between1960 and 2017, a whopping 82% of the total return of the S&P 500 index came from the compound growth of reinvesting dividends.

And if you do like dividends, you should especially love three stocks: AbbVie (NYSE:ABBV), AT&T (NYSE:T), and Welltower (NYSE:WELL). Here’s what makes these dividend stocks really attractive to income-seeking investors.

$100 bills arranged to form the shape of a heart

Image source: Getty Images.

1. AbbVie

AbbVie’s dividend currently yields 4.14%. The big pharma company takes pride in delivering solid dividend hikes year after year. Since 2013, AbbVie has increased its dividend by 140%.

There shouldn’t be a problem with keeping those dividend hikes coming. AbbVie’s payout ratio is a respectable 66%. The drugmaker uses only 42% of its free cash flow to fund the dividend program.

Even better, AbbVie appears to be in great shape to grow its earnings, providing even more flexibility to boost its dividend. The company claims the world’s top-selling drug — Humira. Sales of AbbVie’s cancer drug Imbruvica and hepatitis C drug Mavyret are soaring.

AbbVie also should have some promising new drugs on the way. Market research firm EvaluatePharma ranked the company’s pipeline as the second-best in the biopharmaceutical industry. Potential blockbusters in AbbVie’s pipeline include endometriosis drug elagolix and rheumatoid arthritis drug upadacitinib.

2. AT&T

Investors have liked AT&T’s dividend for a long time — and for good reason. The telecommunications giant’s dividend yield currently stands at 6.23%. AT&T is a member of the elite group of Dividend Aristocrats and has increased its dividend for 34 consecutive years.

Can AT&T keep that streak going for years to come? Probably so. The company currently uses only 40% of its earnings to pay out dividends. There are also a couple of factors that should enable AT&T to grow its earnings more in the future than it has over the last several years.

One of those factors is the company’s acquisition of Time Warner. AT&T expects significant cost synergies from the transaction — around $1.5 billion per year. The company will also be able to offer new bundled packages to its customers, which holds the potential to boost revenue.

Another key factor that should drive growth for AT&T is the launch of 5G networks. These high-speed networks could open up significant new markets for the company in self-driving cars, smart city applications, and virtual reality.

3. Welltower

Welltower’sdividend yield of 6.45% is even more attractive than AT&T’s. The company is the world’s largest healthcare-focused real estate investment trust (REIT), with more than 1,250 healthcare properties. Welltower has paid a dividend for 187 consecutive quarters — nearly 47 years running.

After eight years of hiking its dividend, the company appears to be keeping its dividend steady in 2018. That’s not surprising, considering that Welltower uses nearly 95% of its free cash flow to fund the dividend program and the company has focused on reducing its leverage.

Is the dividend in trouble? I don’t think so. Welltower can depend on steady cash flow from leasing properties to senior housing providers, skilled nursing facilities, and outpatient medical clinics.

Over the long run, Welltower’s dividend should look better and better. The number of Americans aged 85 and older is expected to double in the next two decades. The number of Americans aged 75 and over is projected to grow five times faster than the overall U.S. population. These trends should drive demand for senior housing, which in turn should enable Welltower to grow significantly.

My favorite

My personal favorite among these three great dividend stocks is AbbVie. Granted, its yield is lower than AT&T’s and Welltower’s. However, the drugmaker is increasing its dividend at a much faster rate. Also, AbbVie’s growth prospects are much better over the next few years. Dividends are key to delivering strong total returns, but it definitely helps for the stock price to appreciate nicely as well.

Top 5 Biotech Stocks To Watch For 2019

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the biggest names in the biotechnology sector. The company has already-approved assets (of which there are six so far) and pipeline-based development drugs (of which there are around 15 right now) designed to target a whole host of different indications, from eye disease to heart disease, to pain, cancer, infectious diseases and rare diseases.

You name it, Regeneron is likely going after it.

Well, the company just made an announcement that adds another indication target to the above list and, on the back of the development, has made a move rarely seen in the biotechnology and health care sectors these days — but one that was incredibly popular during the latter third of last century.

Here is a look at the development in question with a discussion of what it means for Regeneron and for the patients that form the population that the company is now targeting.

Top 5 Biotech Stocks To Watch For 2019: ArQule Inc.(ARQL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ArQule, Inc. (NASDAQ:ARQL) Director Ronald M. Lindsay acquired 23,900 shares of the company’s stock in a transaction on Thursday, May 10th. The stock was acquired at an average price of $2.67 per share, for a total transaction of $63,813.00. Following the purchase, the director now directly owns 43,900 shares of the company’s stock, valued at $117,213. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

  • [By Logan Wallace]

    ValuEngine downgraded shares of ArQule (NASDAQ:ARQL) from a strong-buy rating to a buy rating in a research report sent to investors on Saturday.

    Several other brokerages also recently issued reports on ARQL. Zacks Investment Research upgraded shares of ArQule from a hold rating to a buy rating and set a $2.75 target price for the company in a research note on Tuesday, May 8th. B. Riley set a $4.00 target price on shares of ArQule and gave the company a buy rating in a research note on Monday, March 26th. Roth Capital raised their target price on shares of ArQule from $5.00 to $6.00 and gave the company a buy rating in a research note on Tuesday, April 17th. BidaskClub upgraded shares of ArQule from a hold rating to a buy rating in a research note on Saturday, May 19th. Finally, Leerink Swann upgraded shares of ArQule from a market perform rating to an outperform rating in a research note on Thursday, April 5th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of Buy and a consensus price target of $5.35.

  • [By Maxx Chatsko]

    Shares of development-stage biopharma ArQule (NASDAQ:ARQL) rose nearly 17% today after the company announced two appointments to its management team in two newly created positions. Dr. Marc Schegerin will serve as senior vice president, corporate strategy, communication, and finance. Dr. Shirish Hirani will serve as senior vice president, program management and product planning.

  • [By Joseph Griffin]

    ArQule (NASDAQ:ARQL)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Tuesday, Marketbeat Ratings reports. They currently have a $6.00 price target on the biotechnology company’s stock, up from their prior price target of $5.00. Needham & Company LLC’s price target suggests a potential upside of 134.38% from the company’s previous close.

  • [By Cory Renauer]

    What’s behind these dramatic gains? Read on to find out.

    Company Gain in H1 2018 Market Cap
    Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) 270% $1.19 billion
    ArQule, Inc. (NASDAQ:ARQL) 235% $482 million
    Endocyte, Inc. (NASDAQ:ECYT) 222% $959 million
    Madrigal Pharmaceuticals, Inc.(NASDAQ:MDGL) 205% $3.99 billion

    Data source: YCharts.

  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we’ll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month’s Gain
    Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85%
    Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40%
    Vivis Inc. (Nasdaq: VVUS) $0.77 150.41%
    Adomani Inc. (Nasdaq: ADOM) $1.49 137.68%
    NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88%
    Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06%
    Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12%
    ArQule Inc. (Nasdaq: ARQL) $4.88 90.74%
    LiqTech International Inc. (NYSE: LIQT) $0.66 85.60%
    Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month’s gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

Top 5 Biotech Stocks To Watch For 2019: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Keith Speights]

    It’s not exactly David vs. Goliath. However, Bellicum Pharmaceuticals (NASDAQ:BLCM) and Alnylam Pharmaceuticals (NASDAQ:ALNY) are definitely in different leagues right now. Both are clinical-stage biotechs, but Bellicum’s market cap is less than $350 million while Alnylam’s market cap is close to $10 billion.

  • [By Keith Speights]

    I wrote three months ago that I viewed Alnylam Pharmaceuticals (NASDAQ:ALNY) stock as a pretty good pick — but with a couple of qualifications. First, I didn’t think that the biotech would generate returns in 2018 nearly as great as it did last year. Second, I thought that there were even better stocks to buy than Alnylam.

  • [By Max Byerly]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) last issued its quarterly earnings results on Thursday, May 3rd. The biopharmaceutical company reported ($1.41) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.06. The business had revenue of $21.90 million during the quarter, compared to analysts’ expectations of $35.23 million. Alnylam Pharmaceuticals had a negative return on equity of 36.81% and a negative net margin of 565.20%. The business’s quarterly revenue was up 15.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($1.25) earnings per share. equities analysts anticipate that Alnylam Pharmaceuticals, Inc. will post -6.7 earnings per share for the current fiscal year.

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) released first-quarter results last week, but all eyes were looking forward as the company waits for a potential approval of its hereditary TTR amyloidosis (ATTR) drug, patisiran.

Top 5 Biotech Stocks To Watch For 2019: Biogen Idec Inc(BIIB)

Advisors’ Opinion:

  • [By Chris Lange]

    Ionis Pharmaceuticals Inc. (NASDAQ: IONS) shares made a handy gain on Friday after the firm announced an expanded strategic collaboration with Biogen Inc. (NASDAQ: BIIB). Through this partnership, these companies are planning to tackle and develop novel antisense drug candidates for a broad range of neurological diseases.

  • [By Chris Lange]

    Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 4.73 million shares from the previous 4.33 million. The stock recently traded at $291.92, within a 52-week range of $249.17 to $370.57.

  • [By George Budwell]

    Biotech heavyweight Biogen (NASDAQ:BIIB) has now lost over 13% of its value so far this year. To be fair, this year hasn’t been kind to biotechs in general, thanks to President Trump’s aggressive trade policies with China.But Biogen’s value has been declining at a far faster rate than the industry as a whole due to stiffer competition in the all-important multiple sclerosis (MS) space.

  • [By Brian Orelli]

    Likewise,Biogen (NASDAQ:BIIB) and Ionis Pharmaceuticals (NASDAQ:IONS), which have the only SMA drug on the market, are feeling the heat from the promising data with shares down 5.6% and 7.3%, respectively.

  • [By Chris Lange]

    Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 3.86 million shares from the previous 3.45 million. The stock recently traded at $287.00, within a 52-week range of $244.28 to $370.57.

Top 5 Biotech Stocks To Watch For 2019: Amgen Inc.(AMGN)

Advisors’ Opinion:

  • [By ]

    Celgene (CELG) : “I’d rather buy Amgen (AMGN) or Regeneron Pharmaceuticals (REGN) . I think Celgene overpaid for that acquisition a few years ago.”

  • [By Cory Renauer]

    Sanofi took the assessment and started engaging end payers to see if any would offer easy reimbursement for a lower net price that reflects ICER’s assessment, and the industry listened. As of July 1, the partners will cut the net price of Praluent in return for straightforward access for around 25 million Americans covered by theExpress Scripts (NASDAQ:ESRX) national formulary. Thepharmacy benefits manager, and will also remove formulary access for its main competitor, Amgen’s (NASDAQ:AMGN) Repatha.

  • [By Chris Lange]

    Amgen Inc. (NASDAQ: AMGN) saw its short interest fall to 9.62 million shares from the previous level of 9.79 million. Shares were last seen at $178.26, in a 52-week trading range of $153.56 to $201.23.

  • [By Chris Lange]

    Amgen Inc. (NASDAQ: AMGN) saw its short interest rise to 10.46 million shares from the previous level of 9.49 million. Shares were last seen at $171.94, in a 52-week trading range of $152.16 to $201.23.

  • [By Stephan Byrd]

    Private Capital Group LLC boosted its stake in Amgen, Inc. (NASDAQ:AMGN) by 1,703.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,362 shares of the medical research company’s stock after purchasing an additional 2,231 shares during the period. Private Capital Group LLC’s holdings in Amgen were worth $403,000 at the end of the most recent reporting period.

Best Medical Stocks To Buy For 2019

When my friend Seth asked me to invest in his new wine store, the decision was easy…   He'd already answered the most important question you must ask before making an investment.   Most investors forget to ask this question. But as I'll explain today, if you know how to answer it, you'll set yourself apart from the crowd…   I got to know Seth while I was in medical school at the University of North Carolina at Chapel Hill and he was the wine buyer for a local grocery store… He was educated as a chef and was working on his Master Sommelier badge. (A "sommelier" or "wine steward" is the wine expert at high-end restaurants. You must pass an exam to throw around the snooty French title, and "master" is the highest level of certification.)   Seth always gave great suggestions for meal and wine pairings and would remember them months later… As a customer, I could tell he cared about me, listened, and gave great advice (a spectacular combination). So when he approached me about backing his shop… I knew he understood wine and had a passion for it.

Best Medical Stocks To Buy For 2019: Jersey Elec.(a)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Agilent Technologies, Inc. (NYSE: A) to post quarterly earnings at $0.64 per share on revenue of $1.21 billion after the closing bell. Agilent shares rose 0.86 percent to close at $69.45 on Friday.
    Analysts expect Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) to report quarterly earnings at $0.14 per share on revenue of $438.40 million before the opening bell. Hanwha Q CELLS shares fell 0.29 percent to close at $6.92 on Friday.
    NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders. NiSource shares rose 0.08 percent to close at $24.93 on Friday.
    Analysts are expecting Vipshop Holdings Limited (NYSE: VIPS) to have earned $0.18 per share on revenue of $3.10 billion in the latest quarter. Vipshop will release earnings after the markets close. Vipshop shares rose 0.20 percent to $15.14 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Agilent Technologies, Inc. (NYSE: A) which traded down about 10% at $62.51. The stocks 52-week range is $55.60 to $75.00. Volume was 14 million compared to the daily average volume of 2.6 million.

  • [By Dan Caplinger]

    Tuesday was a down day for stocks, with the Dow Jones Industrial Average falling early to triple-digit losses and other major benchmarks declining by a similar percentage. The yield on the 10-year Treasury jumped well above the 3% mark, leading to speculation that a sustained upward move for interest rates could start to sap away some of the strength of the nearly decadelong bull market in stocks. Adding to the downward pressure was badly received news from several prominent individual companies. Switch (NYSE:SWCH), Vipshop Holdings (NYSE:VIPS), and Agilent Technologies (NYSE:A) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Stephan Byrd]

    CIBC Asset Management Inc lessened its holdings in Agilent Technologies (NYSE:A) by 4.5% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,087 shares of the medical research company’s stock after selling 1,377 shares during the period. CIBC Asset Management Inc’s holdings in Agilent Technologies were worth $1,946,000 as of its most recent SEC filing.

  • [By Taylor Cox]

    Notable Earnings

    Agilent Technologies, Inc (NYSE: A) Q2 after hours

    Investor Events

    Spotify Technology (NYSE: SPOT) IPO quiet period expiration
    IPO/ offering lockup expiration for SendGrid, Inc (NYSE: SEND)
    Herbalife Nutrition Ltd (NYSE: HLF) 2-for-1 stock split goes into effect

    Tuesday
    Economic

  • [By ]

    These include: Adobe Systems Inc. (ADBE) , ADT Inc. (ADT) , Agilent Technologies Inc. (A) , Allergan Plc (AGN) , Anthem Inc. (ANTM) , Apple Inc. (AAPL) , Boston Scientific (BSX) , Cigna Corp. (CI) , Discovery Communications (DISCA) and Dr. Pepper Snapple Group Inc. (DPS) .

Best Medical Stocks To Buy For 2019: Navistar International Corporation(NAV)

Advisors’ Opinion:

  • [By Asit Sharma]

    Navistar International Corporation’s (NYSE:NAV)fiscal second-quarter 2018 results, released earlier this month, revealed that the commercial truck manufacturer is utilizing its capacity to take advantage of favorable economic conditions. Revenue rose nearly 16%, to $2.4 billion, during the last three months, and Navistar posted net profit of $55 million against a loss of $80 million in the prior-year quarter.

  • [By Shane Hupp]

    NavCoin (CURRENCY:NAV) traded up 17.9% against the dollar during the 1-day period ending at 15:00 PM E.T. on May 20th. Over the last week, NavCoin has traded up 19.5% against the dollar. One NavCoin coin can currently be bought for about $1.28 or 0.00015092 BTC on exchanges including Cryptopia, Binance, Bittrex and cfinex. NavCoin has a total market capitalization of $80.73 million and $13.02 million worth of NavCoin was traded on exchanges in the last day.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Navistar International (NAV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    NavCoin (CURRENCY:NAV) traded up 3.1% against the US dollar during the 24 hour period ending at 12:00 PM ET on May 14th. NavCoin has a market cap of $69.58 million and approximately $924,266.00 worth of NavCoin was traded on exchanges in the last day. Over the last week, NavCoin has traded 12.8% lower against the US dollar. One NavCoin coin can now be bought for $1.11 or 0.00012616 BTC on cryptocurrency exchanges including LiteBit.eu, Upbit, cfinex and Poloniex.

  • [By Paul Ausick]

    While the transition period from one chief executive officer to another has barely gotten started at Volkswagen, some big changes may already be afoot. VW’s commercial-vehicles unit, Volkswagen Truck & Bus, is looking at the possibility of buying more shares in U.S. truck maker Navistar International Corp. (NYSE: NAV) or even acquiring the whole company outright.

  • [By Motley Fool Staff]

    Navistar International Corporation (NYSE:NAV)Q2 2018 Earnings Conference CallJune 5, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Best Medical Stocks To Buy For 2019: The Hanover Insurance Group, Inc.(THG)

Advisors’ Opinion:

  • [By Max Byerly]

    The Hanover Insurance Group (NYSE:THG) was upgraded by stock analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating in a research report issued on Friday, Marketbeat Ratings reports.

  • [By Logan Wallace]

    Scout Investments Inc. acquired a new position in shares of The Hanover Insurance Group, Inc. (NYSE:THG) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 174,629 shares of the insurance provider’s stock, valued at approximately $20,587,000. Scout Investments Inc. owned about 0.41% of The Hanover Insurance Group at the end of the most recent quarter.

  • [By Joseph Griffin]

    Goelzer Investment Management Inc. reduced its holdings in shares of The Hanover Insurance Group, Inc. (NYSE:THG) by 3.7% during the 1st quarter, HoldingsChannel reports. The fund owned 40,309 shares of the insurance provider’s stock after selling 1,563 shares during the period. Goelzer Investment Management Inc.’s holdings in The Hanover Insurance Group were worth $4,752,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Teacher Retirement System of Texas cut its holdings in The Hanover Insurance Group, Inc. (NYSE:THG) by 36.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,373 shares of the insurance provider’s stock after selling 5,283 shares during the quarter. Teacher Retirement System of Texas’ holdings in The Hanover Insurance Group were worth $1,105,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Best Medical Stocks To Buy For 2019: Brainstorm Cell Therapeutics Inc.(BCLI)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

    Get Brainstorm Cell Therapeutics alerts:

    Brainstorm Cell Therapeutics (BCLI) Issues Quarterly Earnings Results, Beats Expectations By $0.20 EPS (americanbankingnews.com) BrainStorm Announces First Quarter 2018 Financial Results and Provides Corporate and Clinical Highlights (finance.yahoo.com) What analyst predict for Brainstorm Cell Therapeutics NASDAQ:BCLI ? (stockmarketdaily.co) Global Autologous Cell Therapy Market 2022: Market Size, Shares, Revenue, Production, Consumption (thetechnicalprogress.com) Hot Stocks to Observe: Forward Industries, Inc. (NASDAQ:FORD), Nordic American Tankers Limited (NYSE:NAT … (journalfinance.net)

    Shares of Brainstorm Cell Therapeutics traded up $0.12, hitting $3.76, during trading hours on Monday, according to MarketBeat. 1,552 shares of the stock were exchanged, compared to its average volume of 63,674. The company has a market cap of $69.42 million, a P/E ratio of -14.46 and a beta of 1.86. Brainstorm Cell Therapeutics has a one year low of $3.70 and a one year high of $3.85.

  • [By Lisa Levin] Gainers
    Axovant Sciences Ltd. (NASDAQ: AXON) shares rose 23.7 percent to $1.49. Axovant announced strengthening of management team and completion of organization restructuring which "enhanced capabilities in research and business development" and reduced internal headcount by 43 percent.
    Mammoth Energy Services, Inc. (NASDAQ: TUSK) shares jumped 19.8 percent to $37.3148. Mammoth Energy’s subsidiary Cobra signed a new $900 million contract to finish the restoration of critical electrical services and support the initial phase of reconstruction of the electrical utility system in Puerto Rico.
    Acorn International, Inc. (NYSE: ATV) shares gained 19 percent to $34.0201. Acorn shares rose Friday after the company declared a special one-time cash dividend of $14.97 per ADS.
    DHI Group, Inc. (NYSE: DHX) shares surged 19 percent to $2.20.
    My Size, Inc. (NASDAQ: MYSZ) climbed 16.8 percent to $1.18 after the company received a Notice of Allowance from the USPTO for measurement technology patent.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) gained 16.6 percent to $2.32.
    Leju Holdings Limited (NYSE: LEJU) gained 16.5 percent to $1.34 following Q1 beat.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16.5 percent to $26.1499. Evolus named Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development.
    Jupai Holdings Limited (NYSE: JP) shares gained 15 percent to $26.29 after reporting Q1 results.
    Momo Inc. (NASDAQ: MOMO) shares gained 15 percent to $44.7702 after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Windstream Holdings, Inc. (NASDAQ: WIN) rose 15 percent to $7.075.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) gained 14.4 percent to $2.746.
    American Woodmark Corporation (NASDAQ: AMWD) climbed 14.2 percent to $101.10 after the company reported upbeat Q4 results.
    Savara Inc. (NAS
  • [By Logan Wallace]

    Maxim Group set a $9.00 target price on Brainstorm Cell Therapeutics (NASDAQ:BCLI) in a research note issued to investors on Monday morning. The brokerage currently has a buy rating on the biotechnology company’s stock.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

Best Medical Stocks To Buy For 2019: (SMPQY)

Advisors’ Opinion:

  • [By ]

    I studied the management running the company and found fantastic professionals coming from large institutions like Novartis AG (NYSE:NVS), Sun Pharmaceuticals Industries (OTCPK:SMPQY), AstraZeneca Group plc (NYSE:AZN), or Endo International plc (NASDAQ

Hot Insurance Stocks To Own For 2019

While looking through my portfolio, I realized I hold 300 shares of General Electric (NYSE: GE) from way, way back. I used to own 1000, but sold most off long before the financial crises. I’ve pretty much committed myself to just hold these shares, come whatever, and see what happens. I’ve invested the proceeds from the 700 sold shares well over the years, so GE is very small part of the portfolio.

Reading through corporate conference calls can be an exercise in MEGO (My Eyes Glaze Over). GE’s call, however, had some rather spicy moments. With so many serious GE articles lately, I’m going to take a rather lighthearted look through some of the better “Zingers” from the call.

Let the comedic gold begin.

Highlights from the Call

First up – C.E.O. John Flannery – who has clearly been taking notes in buzzword school.

John Flannery

I recognize that the news we’ve shared in that time, specifically around Power and Insurance, has been tough.

Starts with contrition – reasonable

Hot Insurance Stocks To Own For 2019: American International Group Inc.(AIG)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the media stories that may have effected Accern’s rankings:

    Get American International Group alerts:

    AIG’s loss for European business worsens in 2017 (businessinsurance.com) $1.26 EPS Expected for American International Group (AIG) This Quarter (americanbankingnews.com) UBS: Buy AIG After Earnings Estimates ‘Bottom Out’ (finance.yahoo.com) American International Group (AIG) Stock Rating Upgraded by UBS (americanbankingnews.com) American International Group (AIG) Receives Average Recommendation of “Hold” from Analysts (americanbankingnews.com)

    American International Group traded up $0.36, hitting $55.15, during mid-day trading on Friday, MarketBeat.com reports. The stock had a trading volume of 9,821,608 shares, compared to its average volume of 6,828,715. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.27 and a quick ratio of 0.27. American International Group has a 1-year low of $49.57 and a 1-year high of $67.30. The firm has a market cap of $49.51 billion, a P/E ratio of 22.98, a PEG ratio of 1.01 and a beta of 1.24.

  • [By ]

    Insurance company American International Group Inc. (AIG) stock fell 5.3% as harsh winter weather weighed on profits. But the company’s long-term care exposure is relatively minimal.

  • [By Logan Wallace]

    Gifford Fong Associates acquired a new position in shares of American International Group (NYSE:AIG) in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 44,100 shares of the insurance provider’s stock, valued at approximately $2,400,000.

  • [By Lee Jackson]

    American International Group Inc. (NYSE: AIG) was only a DJIA member for four years when it was removed on September 22, 2008. In an ironical twist, AIG was replaced with Kraft Foods, which only lasted about four years on the index. AIG was removed during the credit and mortgage crisis and was ejected after the government propped up the insurer with stimulus funds. The shares closed most recently at $55.43.

  • [By Stephan Byrd]

    Suntrust Banks Inc. boosted its position in shares of American International Group Inc (NYSE:AIG) by 12.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,736 shares of the insurance provider’s stock after purchasing an additional 4,048 shares during the period. Suntrust Banks Inc.’s holdings in American International Group were worth $1,998,000 at the end of the most recent reporting period.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Hot Insurance Stocks To Own For 2019: Topdanmark A/S (TOP)

Advisors’ Opinion:

  • [By Logan Wallace]

    TopCoin (CURRENCY:TOP) traded down 15.4% against the dollar during the 1-day period ending at 7:00 AM E.T. on June 21st. During the last seven days, TopCoin has traded up 4% against the dollar. TopCoin has a market cap of $0.00 and approximately $123.00 worth of TopCoin was traded on exchanges in the last day. One TopCoin coin can currently be bought for about $0.0010 or 0.00000015 BTC on popular exchanges.

Hot Insurance Stocks To Own For 2019: W.R. Berkley Corporation(WRB)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on W. R. Berkley (WRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on W. R. Berkley (WRB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    W. R. Berkley (NYSE: WRB) and State Auto Financial (NASDAQ:STFC) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Hot Insurance Stocks To Own For 2019: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) takes such pride in its rock-solid financial condition that it uses an actual rock — the Rock of Gibraltar– as its corporate symbol. Prudential Financial backs up that claim with a balance sheet that has more cash, cash equivalents, and short-term investmentsthan total debt on it. It also claims a debt-to-equity ratio around 0.6 and a current ratio around 1.0, which are further signs of a solid financial condition.

  • [By Jason Hall, Chuck Saletta, and Reuben Gregg Brewer]

    But that doesn’t mean you need to make risky bets to capture solid returns, either, and buying solid companies at reasonable prices can help create a margin of safety and improve your returns, while also decreasing your risk of permanent losses. Three stocks that meet these criteria are small healthcare real-estate specialistCaretrust REIT Inc(NASDAQ:CTRE), financial services giantPrudential Financial Inc(NYSE:PRU), and energy behemothExxonMobil Corporation(NYSE:XOM).

  • [By Ethan Ryder]

    American Equity Investment Life (NYSE: AEL) and Prudential Financial (NYSE:PRU) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Prudential Financial (PRU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Flippin Bruce & Porter Inc. grew its holdings in shares of Prudential Financial (NYSE:PRU) by 2.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 61,363 shares of the financial services provider’s stock after acquiring an additional 1,391 shares during the period. Flippin Bruce & Porter Inc.’s holdings in Prudential Financial were worth $6,354,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its position in Prudential Financial Inc (NYSE:PRU) by 29.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 312,450 shares of the financial services provider’s stock after selling 132,238 shares during the period. State of Tennessee Treasury Department owned approximately 0.07% of Prudential Financial worth $32,354,000 at the end of the most recent reporting period.

Hot Insurance Stocks To Own For 2019: Aon Corporation(AON)

Advisors’ Opinion:

  • [By Stephan Byrd]

    US Bancorp DE raised its stake in shares of Aon (NYSE:AON) by 3.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 40,448 shares of the financial services provider’s stock after acquiring an additional 1,178 shares during the quarter. US Bancorp DE’s holdings in AON were worth $5,676,000 as of its most recent filing with the SEC.

  • [By Logan Wallace]

    CorVel (NASDAQ: CRVL) and AON (NYSE:AON) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and valuation.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P

Top Clean Energy Stocks To Watch Right Now

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-508336438&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/508336438/960×0.jpg?fit=scale&q; data-height=&q;637&q; data-width=&q;960&q;&g; An aerial view of the solar mirrors at the Noor 1 Concentrated Solar Power plant in Morocco. The North African country has approved a new $2.4bn 800MW scheme. (FADEL SENNA/AFP/Getty Images)

Emerging markets dominated investment in clean energy in the first quarter of 2018, with more than 40% of funding going to projects in China, while there were notable developments in Mexico, Morocco, Indonesia and Vietnam.

Total investment for the first three months of the year was $61.1 billion, 10% lower than the same period in 2017, according to Bloomberg New Energy Finance (BNEF). Using slightly different criteria, Clean Energy Pipeline said that the figure was $62.1 billion.

One reason for the fall in investment was a 19% drop in solar funding, partly as a result of a 7% fall in the price of photovoltaic equipment over the past year, and partly because of weaker activity in some markets.

Top Clean Energy Stocks To Watch Right Now: Frontline Ltd.(FRO)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
    Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
    DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
    Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
    Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
    Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
    Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
    Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
    Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY
  • [By ]

    What Happened
    Shares of Frontline Ltd. (NYSE:FRO) surged more than 13% by 10:00 a.m. EDT on Thursday after the oil tanker company posted better-than-expected first-quarter results.

  • [By Shane Hupp]

    Diana Shipping (NYSE: DSX) and Frontline (NYSE:FRO) are both small-cap transportation companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

Top Clean Energy Stocks To Watch Right Now: Renewable Energy Group, Inc.(REGI)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    However, there could be quite a bit more long-term growth ahead of the business. That’s true considering its historical slow-and-steady expansion, but also when investors factor in a recent proposal from the U.S. Environmental Protection Agency that would increase the company’s U.S. market opportunity 16% beginning in 2020. A global shipping fuel standard that goes into effect then should provide an even bigger growth opportunity. Those are just some of the reasons investors might want to get familiar with Renewable Energy Group (NASDAQ:REGI).

  • [By Lisa Levin]

    Monday afternoon, the energy shares rose 0.73 percent. Meanwhile, top gainers in the sector included Renewable Energy Group, Inc. (NASDAQ: REGI), up 11 percent, and Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) up 7 percent.

  • [By Lisa Levin] Gainers
    Acacia Communications, Inc. (NASDAQ: ACIA) shares rose 18.3 percent to $37.25 in pre-market trading after gaining 1.74 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 12.1 percent to $2.69 in pre-market trading after surging 4.80 percent on Friday.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 10.9 percent to $109.75 in pre-market trading after Bloomberg reported that the China’s Commerce Ministry has restarted its review of QUALCOMM Incorporated’s (NASDAQ: QCOM) proposed takeover of NXP Semiconductors.
    Renewable Energy Group, Inc. (NASDAQ: REGI) rose 10.6 percent to $15.20 in pre-market trading. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    NeoPhotonics Corporation (NYSE: NPTN) rose 10 percent to $6.40 in pre-market trading.
    Vaxart, Inc. (NASDAQ: VXRT) shares rose 8 percent to $5.54 in pre-market trading after gaining 2.19 percent on Friday.
    Profire Energy, Inc. (NASDAQ: PFIE) rose 7.3 percent to $4.58 in pre-market trading after gaining 6.22 percent on Friday.
    Marvell Technology Group Ltd. (NASDAQ: MRVL) rose 7 percent to $22.49 in pre-market trading after falling 1.96 percent on Friday.
    Oclaro, Inc. (NASDAQ: OCLR) shares rose 6.9 percent to $9.16 in pre-market trading.
    TransEnterix, Inc. (NYSE: TRXC) rose 5.7 percent to $2.24 in pre-market trading after gaining 3.92 percent on Friday.
    CVR Refining, LP (NYSE: CVRR) rose 5.4 percent to $19.70 in pre-market trading.
    Federal Agricultural Mortgage Corporation (NYSE: AGM) rose 5.2 percent to $92.95 in pre-market trading.
    International Game Technology PLC (NYSE: IGT) rose 5.2 percent to $29.94 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares rose 5.1 percent to $66.30 in the pre-market trading session.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5 percent to $10.70 in pre-market trading after climbing 15.66 percent on Friday.
    Finisar
  • [By Stephan Byrd]

    Renewable Energy Group (NASDAQ:REGI) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a report released on Monday.

  • [By Joseph Griffin]

    Renewable Energy Group Inc (NASDAQ:REGI)’s share price reached a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $18.10 and last traded at $17.95, with a volume of 27770 shares changing hands. The stock had previously closed at $17.70.

  • [By Lisa Levin]

    Tuesday morning, the energy shares rose 0.73 percent. Meanwhile, top gainers in the sector included Renewable Energy Group, Inc. (NASDAQ: REGI), up 11 percent, and Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) up 7 percent.

Top Clean Energy Stocks To Watch Right Now: Marathon Oil Corporation(MRO)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Marathon Oil (NYSE:MRO) is another oil producer built for $50 oil. At that level, Marathon can generate enough cash to grow its U.S. oil production 25% to 30% this year, while at $60 oil, the company can produce $500 million in free cash — and even more at current prices. Marathon Oil has a range of options for that money, including buying back shares, boosting the dividend, paying off debt, or acquiring more drillable land.

  • [By Zacks]

    Oil production is surging in Canada but producers are far from happy as their profit margin is sinking and they are striving to stay competitive with their U.S. counterparts. While upstream companies like Marathon Oil Corporation (NYSE: MRO), Hess Corporation (NYSE: HES) and others are enjoying the shale boom and rebound in prices in the United States, their Canadian counterparts like Cenovus Energy Inc. (NYSE: CVE) and others are thinking of reducing production. The primary reason behind this is the shortage of pipelines in the country. In short, pipeline construction in Canada has failed to keep pace with rising domestic oil production – the heavier sour variety churned out of the oil sands –  resulting in infrastructural bottlenecks. This has also forced producers to give away their products at a discounted rate.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close was Marathon Oil Corp. (NYSE: MRO) which traded down over 5% at $19.99. The stocks 52-week range is $10.55 to $22.12. Volume was over 17 million compared to the daily average volume of 12.8 million.

Top Clean Energy Stocks To Watch Right Now: UFP Technologies Inc.(UFPT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media coverage about UFP Technologies (NASDAQ:UFPT) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. UFP Technologies earned a daily sentiment score of 0.03 on Accern’s scale. Accern also assigned headlines about the industrial products company an impact score of 47.0533500754779 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Logan Wallace]

    China XD Plastics (NASDAQ: CXDC) and UFP Technologies (NASDAQ:UFPT) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.

  • [By Joseph Griffin]

    UFP Technologies (NASDAQ: UFPT) and China XD Plastics (NASDAQ:CXDC) are both small-cap industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings.

JPMorgan Chase & Co. Analysts Give Vinci (DG) a €101.00 Price Target

JPMorgan Chase & Co. set a €101.00 ($117.44) price objective on Vinci (EPA:DG) in a research report report published on Monday. The firm currently has a buy rating on the stock.

Several other equities analysts have also weighed in on the stock. UBS Group set a €93.50 ($108.72) price objective on shares of Vinci and gave the company a buy rating in a report on Wednesday, June 6th. Societe Generale set a €100.70 ($117.09) price objective on shares of Vinci and gave the company a buy rating in a report on Wednesday, May 2nd. Goldman Sachs Group set a €104.00 ($120.93) price objective on shares of Vinci and gave the company a buy rating in a report on Monday, April 30th. Credit Suisse Group set a €95.00 ($110.47) price objective on shares of Vinci and gave the company a buy rating in a report on Monday, March 5th. Finally, Royal Bank of Canada set a €101.00 ($117.44) price objective on shares of Vinci and gave the company a buy rating in a report on Wednesday, June 13th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Vinci has a consensus rating of Buy and an average target price of €92.67 ($107.75).

Get Vinci alerts:

Vinci opened at €82.08 ($95.44) on Monday, MarketBeat.com reports. Vinci has a 12-month low of €69.54 ($80.86) and a 12-month high of €88.80 ($103.26).

Vinci Company Profile

VINCI SA engages in the concessions and contracting businesses worldwide. The company designs, finances, builds, and operates infrastructure and facilities comprising motorway, bridge and tunnel, airport, rail, and stadium facilities. It operates motorway concession with a network of 4,422 kilometers in France; and 35 airports worldwide.

Analyst Recommendations for Vinci (EPA:DG)

Benzinga's Option Alert Recap From July 24

Related TEX The Goldman Pair Trade In Machinery: PACCAR Upgraded, Terex Downgraded Benzinga's Top Upgrades, Downgrades For June 15, 2017
Related FOSL 5 Worst Investment Ideas Of 2017 Thus Far Why Fossil (FOSL) is a Touch-Me-Not Stock for Investors

Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity.

Here's a recap of the option alerts from Monday, July 24, 2017. All timestamps are in Eastern Time.

3:51:38 pm: TEX Terex Aug 18 $40 Puts at the Ask: 1000 @ $2.201 vs 1 OI; Ref=$38.895

3:38:21 pm: FOSL Fossil Aug 18 $10 Puts at the Bid: 5258 @ $0.7 vs 3575 OI; Ref=$10.435

3:11:53 pm: LUV Southwest Air Jan 19 $60 Calls Sweep (2) at the Bid: 1750 @ $4.35 vs 1564 OI; Ref=$59.915

2:32:53 pm: CVNA Carvana Aug 18 $22.5 Calls at the Ask: 575 @ $1.9 vs 129 OI; Ref=$20.95

1:04:40 pm: CAT Caterpillar Aug 18 $115 Calls Sweep (30) at the Bid: 5070 @ $0.53 vs 2634 OI; Ref=$107.92

12:21:36 pm: MCD McDonald's Aug 18 $160 Calls at the Bid: 5968 @ $0.58 vs 2380 OI; Ref=$152.31

12:21:00 pm: FB Facebook Aug 18 $170 Puts Sweep (34) at the Ask: 3469 @ $7.901 vs 851 OI; Ref=$164.9069

12:08:27 pm: CMI Cummins Aug 18 $155 Puts at the Bid: 1392 @ $1.0 vs 324 OI; Ref=$166.42

11:42:27 am: HCA HCA Healthcare Aug 18 $85 Puts Sweep (32) at the Ask: 778 @ $1.558 vs 680 OI; Ref=$86.35

11:34:40 am: XRAY Dentsply Oct 20 $65 Calls Above Ask!: 2100 @ $1.531 vs 1930 OI; Ref=$62.48

11:31:15 am: SBUX Starbucks Aug 25 $59 Calls Sweep (12) at the Ask: 528 @ $1.02 vs 33 OI; Ref=$57.95

11:28:00 am: LC Lending Club Jan 19 $6 Calls at the Ask: 900 @ $0.35 vs 353 OI; Ref=$5.1375

11:12:45 am: STMP Stamps.com Aug 18 $180 Calls at the Ask: 500 @ $1.75 vs 81 OI; Ref=$151.48

10:53:09 am: AAPL Apple Aug 11 $149 Puts at the Bid: 3350 @ $2.61 vs 2270 OI; Ref=$151.2

10:42:10 am: PYPL PayPal Aug 11 $58 Puts at the Bid: 700 @ $1.45 vs 12 OI; Ref=$58.5188

10:26:39 am: MIK Michael's Aug 18 $20 Calls Sweep (2) at the Ask: 6192 @ $0.475 vs 137 OI; Ref=$19.28

10:05:16 am: YNDX Yandex Nov 17 $31 Calls Sweep (27) at the Ask: 1291 @ $3.701 vs 63 OI; Ref=$31.97

9:55:07 am: LVS LVS Fri $62 Puts at the Bid: 1126 @ $0.73 vs 467 OI; Ref=$63.211

9:42:29 am: AN AutoNation Aug 18 $42 Puts at the Bid: 2000 @ $1.25 vs 191 OI; Ref=$42.52

9:41:41 am: GRA WR Grace Aug 18 $72.5 Calls at the Ask: 500 @ $1.851 vs 377 OI; Ref=$71.72

Keep up with unusual trading activity and the financial news you need in real-time with Benzinga Pro.

Pool (POOL) Downgraded by Zacks Investment Research to “Hold”

Pool (NASDAQ:POOL) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday.

According to Zacks, “Pool shares have outperformed the industry in the past year. In fact, first-quarter 2018 marked the 31st consecutive quarter of year-over-year growth for Pool in sales. Notably, the company should continue to benefit in the near term backed by base business sales growth and favorable trends in the housing market. Additionally, continuous growth in the remodel and replacement sectors of its business is a major positive. The company’s leading market share position and opportunistic expansion strategies position it well for revenue growth. Earnings estimates for 2018 have also been revised upward over the past two months, reflecting analysts’ confidence in the company’s future potential. Nonetheless, seasonality of the company’s business and macroeconomic headwinds owing to large global presence raise concern.”

Get Pool alerts:

A number of other brokerages have also issued reports on POOL. Berenberg Bank started coverage on shares of Pool in a report on Wednesday, June 20th. They issued a “hold” rating and a $157.00 price target on the stock. BidaskClub lowered shares of Pool from a “buy” rating to a “hold” rating in a report on Saturday, April 28th. ValuEngine raised shares of Pool from a “hold” rating to a “buy” rating in a report on Saturday, May 12th. Finally, Robert W. Baird lowered shares of Pool from an “outperform” rating to a “neutral” rating and set a $131.00 target price on the stock. in a research note on Tuesday. Four analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Pool presently has a consensus rating of “Buy” and a consensus price target of $148.60.

Pool traded down $2.18, reaching $150.95, during trading hours on Wednesday, Marketbeat.com reports. The stock had a trading volume of 150,046 shares, compared to its average volume of 179,554. The firm has a market cap of $6.20 billion, a PE ratio of 37.83 and a beta of 0.82. Pool has a 52 week low of $97.25 and a 52 week high of $157.52. The company has a quick ratio of 0.65, a current ratio of 1.97 and a debt-to-equity ratio of 2.19.

Pool (NASDAQ:POOL) last announced its quarterly earnings results on Thursday, April 19th. The specialty retailer reported $0.75 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.04. The business had revenue of $585.90 million for the quarter. Pool had a net margin of 7.10% and a return on equity of 74.42%. Pool’s revenue was up 7.2% on a year-over-year basis. During the same period last year, the business earned $0.52 EPS. sell-side analysts expect that Pool will post 5.53 earnings per share for the current fiscal year.

Pool announced that its Board of Directors has authorized a share repurchase plan on Thursday, May 3rd that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the specialty retailer to reacquire up to 3.5% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s management believes its stock is undervalued.

In related news, General Counsel Jennifer M. Neil sold 6,012 shares of Pool stock in a transaction dated Thursday, April 26th. The shares were sold at an average price of $137.08, for a total transaction of $824,124.96. Following the completion of the transaction, the general counsel now directly owns 20,100 shares of the company’s stock, valued at approximately $2,755,308. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Mark W. Joslin sold 13,000 shares of Pool stock in a transaction dated Friday, May 11th. The shares were sold at an average price of $150.00, for a total transaction of $1,950,000.00. Following the transaction, the chief financial officer now directly owns 136,701 shares of the company’s stock, valued at $20,505,150. The disclosure for this sale can be found here. Insiders have sold a total of 32,512 shares of company stock worth $4,776,350 in the last ninety days. Insiders own 6.00% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Mount Yale Investment Advisors LLC purchased a new position in Pool during the 1st quarter valued at about $487,000. Amalgamated Bank raised its holdings in Pool by 6.5% in the first quarter. Amalgamated Bank now owns 8,754 shares of the specialty retailer’s stock worth $1,280,000 after buying an additional 533 shares during the last quarter. Principal Financial Group Inc. raised its holdings in Pool by 2.5% in the first quarter. Principal Financial Group Inc. now owns 205,748 shares of the specialty retailer’s stock worth $30,085,000 after buying an additional 4,922 shares during the last quarter. Summit Trail Advisors LLC raised its holdings in Pool by 10,523.4% in the first quarter. Summit Trail Advisors LLC now owns 1,712,925 shares of the specialty retailer’s stock worth $1,713,000 after buying an additional 1,696,801 shares during the last quarter. Finally, WINTON GROUP Ltd purchased a new position in Pool in the first quarter worth about $8,264,000. 94.41% of the stock is owned by institutional investors.

About Pool

Pool Corporation distributes swimming pool supplies, equipment, and related leisure products in North America, Europe, South America, and Australia. The company offers maintenance products, including chemicals, supplies, and pool accessories; repair and replacement parts for pool equipment, such as cleaners, filters, heaters, pumps, and lights; packaged pool kits comprising walls, liners, braces, and coping for in-ground and above-ground pools; pool equipment and components for new pool construction and the remodeling of existing pools; and irrigation and landscape products consisting of irrigation system components, and professional lawn care equipment and supplies.

Get a free copy of the Zacks research report on Pool (POOL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Pool (NASDAQ:POOL)